On this page, you’ll find information on how bamlanivimab and etesevimab are being distributed together across the country and how to find an infusion site near you. The Access FAQs below also provide more information regarding the process to order product, including reimbursement.
How to order product
The federal government has purchased and is directing the distribution of Lilly’s COVID-19 antibody therapies. Healthcare facilities can now order product directly from the distributor, AmerisourceBergen.Order COVID-19 antibody treatments
If you have additional questions, please know you can always call our dedicated Lilly COVID Hotline at 1-855-545-5921.
If you have a question about enrolling a patient in a clinical trial, please visit our Lilly Trial Guide.
Find an infusion site near you
States are partnering with the National Infusion Center Association (NICA) and the Department of Health & Human Services (HHS) to make it easier to identify product and infusion locations by state.* Click below to find an infusion site near you. Please note that a site’s inclusion in this tool does not imply current availability of doses. For additional help finding an infusion center, please call the Lilly COVID Hotline at 1-855-545-5921.Go (NICA)
Frequently Asked Questions
FAQs regarding access to bamlanivimab and etesevimab together
Due to variant prevalence, some states may not be eligible to order bamlanivimab and etesevimab together anymore. Before reviewing the FAQs below, please visit this website to confirm if your state is included in the list of impacted states. As of May 12, 2021, the only state impacted is Illinois.
Clinical investigators, hospitals or clinical sites interested in participating in one of Lilly’s clinical trials for a potential COVID-19 treatment should call 1-877-CT-LILLY (1-877-285-4559) or email email@example.com.